/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

David I. Marks

University Hospitals Bristol NHS Foundation Trust(GB)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

360

Papers

20.8K

Citations

74

h-index

198

i10-index

David I. Marks is an academic researcher from University Hospitals Bristol NHS Foundation Trust. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Hematopoietic Stem Cell Transplantation & Chronic Myeloid Leukemia Treatments. The author has an h-index of 74, co-authored 306 publications.

ORCID: 0000-0003-3821-6352

Research Topics

Acute Lymphoblastic Leukemia research Hematopoietic Stem Cell Transplantation Chronic Myeloid Leukemia Treatments Acute Myeloid Leukemia Research CAR-T cell therapy research

Papers by this author

works

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

2007 · Blood · 780 citations

https://doi.org/10.1182/blood-2007-10-116582

Anthony H. Goldstone Susan Richards Hillard M. Lazarus Martin S. Tallman

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

2015 · Biology of Blood and Marrow Transplantation · 403 citations

https://doi.org/10.1016/j.bbmt.2015.07.032

Navneet S. Majhail Stephanie Farnia Paul A. Carpenter Richard E. Champlin

Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning

2008 · Biology of Blood and Marrow Transplantation · 162 citations

https://doi.org/10.1016/j.bbmt.2007.11.004

Parameswaran Hari Jeanette Carreras Mei-Jie Zhang Robert Peter Gale

Second Unrelated Donor Hematopoietic Cell Transplantation for Primary Graft Failure

2010 · Biology of Blood and Marrow Transplantation · 99 citations

https://doi.org/10.1016/j.bbmt.2010.02.013

Jeffrey Schriber Afiba Manza‐A. Agovi Vincent T. Ho Karen K. Ballen

A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR

2009 · Biology of Blood and Marrow Transplantation · 91 citations

https://doi.org/10.1016/j.bbmt.2009.08.011

Hillard M. Lazarus Mei‐Jie Zhang Jeanette Carreras Brandon Hayes‐Lattin

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myelogenous Leukemia (AML) in Adults

2010 · Biology of Blood and Marrow Transplantation · 76 citations

https://doi.org/10.1016/j.bbmt.2010.04.009

Willis H. Navarro Afiba Manza‐A. Agovi Brent R. Logan Karen K. Ballen

Research topics

topics

Acute Lymphoblastic Leukemia research

Hematopoietic Stem Cell Transplantation

Chronic Myeloid Leukemia Treatments

Acute Myeloid Leukemia Research

CAR-T cell therapy research

Chat about Author

Papers

Chat

Click to start Chat